NCT02322957View on ClinicalTrials.gov

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

July 31, 2015

Conditions
Acute Herpes Zoster
Interventions
DRUG

FV-100

Subjects will be randomized to one of two treatment sequences: AB or BA.

Sponsors
All Listed Sponsors
lead

ContraVir Pharmaceuticals, Inc.

INDUSTRY